|
||||||||
![]() |
||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced. |
|||||||||||||||||||||||||||||||||||||||||||||||||
![]() Download
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| PS-CFP2 | BspE I | Bgl II | Sac I | EcoR I | Sal I | Kpn I | Apa I | BamH I | Stops | ||||||||||||||||||||||
| Xho I* | Hind III | Pst I | Sac II | Xba I# | Bcl I# | ||||||||||||||||||||||||||
| CTG.TAC.AAG. | TCC.GGA. | CTC. | AGA.T | CT | .C | GA.G | CT.C | AA.GCT.T | C | G.AAT.T | C | T.GCA. | G | TC.GAC | .GGT.A | CC. | GC | G.G | G | C.CC | G. | GG | A.TCC. | ACC.GGA. | TC | T.AG | A. | TAA. | C | TG.A | TC.A |
* - not unique site.
# - sites are blocked by dam methylation. If you wish to digest the vector with these enzymes, you will need to transform the vector into a dam- host and make fresh DNA.
pPS-CFP2-C is a mammalian expression vector encoding cyan-to-green fluorescent protein
The vector backbone contains immediate early promoter of cytomegalovirus (PCMV IE) for protein expression, SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in E. coli, and f1 origin for single-stranded DNA production. SV40 polyadenylation signals (SV40 poly A) direct proper processing of the 3'-end of the reporter mRNA.
SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in E. coli. Kanr/Neor gene is linked with herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signals.
Generation of
A localization signal (or a gene of interest) should be cloned into MCS of the vector. It will be expressed as a fusion to the
Note: The plasmid DNA was isolated from dam+-methylated E. coli. Therefore some restriction sites are blocked by methylation. If you wish to digest the vector using such sites you will need to transform the vector into a dam- host and make fresh DNA.
Expression in mammalian cells
pPS-CFP2-C can be transfected into mammalian cells by any known transfection method. CMV promoter provides strong, constitutive expression of
Propagation in E. coli
Suitable host strains for propagation in E. coli include DH5alpha, HB101, XL1-Blue, and other general purpose strains. Plasmid incompatibility group is pMB1/ColE1. The vector confers resistance to kanamycin (30 μg/ml) to E. coli hosts. Copy number in E. coli is about 500.
Location of features
PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
Kozak consensus translation initiation site: 606-616
Start codon (ATG): 613-615
Stop codon: 1405-1407
Last amino acid in
MCS: 1327-1412
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1547-1552 & 1576-1581
mRNA 3' ends: 1585 & 1597
f1 single-strand DNA origin: 1644-2099
Eukaryotic promoter for expression of Kanr gene
-35 region: 2161-2166
-10 region: 2184-2189
Transcription start point: 2196
SV40 origin of replication: 2440-2575
SV40 early promoter
Enhancer (72-bp tandem repeats): 2273-2344 & 2345-2416
21-bp repeats: 2420-2440, 2441-2461 & 2463-2483
Early promoter element: 2496-2502
Major transcription start points: 2492, 2530, 2536 & 2541
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 2624-2626
Stop codon: 3416-3418
G->A mutation to remove Pst I site: 2806
C->A (Arg to Ser) mutation to remove BssH II site: 3152
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3654-3659 & 3667-3672
pUC plasmid replication origin: 4003-4646
Photoactivatable FP-related products are intended to be used by academic (non-commercial) entities and for research purposes only. Any use of the proprietary nucleic acid or protein other than for research use or by a commercial entity is strictly prohibited. Transfer of this product by purchaser to any other party is specifically prohibited.
The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.
To the best of our knowledge, these products do not require a Material Safety Data Sheet. However, all the properties of these products (and, if applicable, each of their components) have not been thoroughly investigated. Therefore, we recommend that you use gloves and eye protection, and wear a laboratory coat when working with these products.
|
Copyright 2002-2010 Evrogen. All rights reserved. Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, Tel +7(495)988-4084, Fax +7(495)988-4085, e-mail:evrogen@evrogen.com |